---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-024691"
form_type: "8-K"
ticker: "MTNB"
cik: "0001582554"
company_name: "Matinas BioPharma Holdings, Inc."
filed_at: "2025-11-21T23:59:59+00:00"
generated_at: "2026-05-16T17:37:20.128353+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Matinas BioPharma CFO Keith Kucinski to resign effective Jan 17, 2026

## Summary
- Keith Kucinski notified his resignation as CFO on Nov 18, 2025.
- Resignation effective Jan 17, 2026; he is pursuing other opportunities.
- No disagreement with the Company regarding operations, policies, or practices.
- No successor named; CEO Jerome Jabbour signed the filing.

## SEC filing metadata
- accession: 0001493152-25-024691
- form_type: 8-K
- ticker: MTNB
- cik: 0001582554
- company_name: Matinas BioPharma Holdings, Inc.
- filed_at: 2025-11-21T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1582554/000149315225024691/0001493152-25-024691-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1582554/000149315225024691/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-024691
- JSON: https://secwatch.observer/filing/0001493152-25-024691.json
- Plain text: https://secwatch.observer/filing/0001493152-25-024691.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.